Association of 11 variants of the dopaminergic and cognitive pathways genes with major depression, schizophrenia and bipolar disorder in the Pakistani population.

The dopaminergic pathways control neural signals that modulate mood and behaviour along and have a vital role in the aetiology of major depression (MDD), schizophrenia (SHZ) and bipolar disorder (BD). Genome-wide association studies (GWAS) have reported several dopaminergic and cognitive pathway genes association with these disorders however, no such comprehensive data was available regarding the Pakistani population. Therefore, the present study was conducted to analyse the 11 genetic variants of dopaminergic and cognitive system genes in MDD, SHZ, and BD in the Pakistani population. A total of 1237 subjects [MDD n = 479; BD n = 222; SHZ n = 146; and controls n = 390], were screened for 11 genetic variants through polymerase chain reaction (PCR) techniques. Univariant followed by multivariant logistic regression analysis was applied to determine the genetic association. Significant risk associations were observed for rs4532 and rs1799732 with MDD; and rs1006737 and rs2238056 with BD. However, after applying multiple test corrections rs4532 and rs1799732 association did not remain significant for MDD. Moreover, a protective association was found for three variants; DRD4-120bp, rs10033951 and rs2388334 in the current cohort. In conclusion, the current study revealed the risk association of single nucleotide polymorphisms (SNPs) rs1006737 and rs2238056 with BD and the protective effect of the DRD4-120bp variant in MDD and BD, of rs2388334 in BD and of rs10033951 in MDD, BD, and SHZ in the current Pakistani cohort. Thus, the study is valuable in understanding the genetic basis of MDD, BD and SHZ in the Pakistani population, which may pave the way for future functional studies.

[1]  O. Riggio,et al.  Neurological and psychiatric effects of hepatitis C virus infection , 2021, World journal of gastroenterology.

[2]  Jun Yao,et al.  The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis , 2020, BMC Medical Genetics.

[3]  Paul J. Harrison,et al.  Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1–5, MAOA, MAOB, TH, VMAT1, and VMAT2 , 2019, Biological Psychiatry.

[4]  E. Feczko,et al.  The Heterogeneity Problem: Approaches to Identify Psychiatric Subtypes , 2019, Trends in Cognitive Sciences.

[5]  R. G. Correa,et al.  Dopamine: Functions, Signaling, and Association with Neurological Diseases , 2018, Cellular and Molecular Neurobiology.

[6]  JP Kesby,et al.  Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience , 2018, Translational Psychiatry.

[7]  Jakob Grove,et al.  Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder , 2017, bioRxiv.

[8]  Tianzi Jiang,et al.  Polygenic risk for five psychiatric disorders and cross-disorder and disorder-specific neural connectivity in two independent populations , 2017, NeuroImage: Clinical.

[9]  Y. Kamatani,et al.  A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder , 2017, Molecular Psychiatry.

[10]  Q. Kan,et al.  −141C insertion/deletion polymorphism of the dopamine D2 receptor gene is associated with schizophrenia in Chinese Han population: Evidence from an ethnic group‐specific meta‐analysis , 2016, Asia-Pacific psychiatry : official journal of the Pacific Rim College of Psychiatrists.

[11]  Y. Zou,et al.  The -141C Ins/Del and Taq1A polymorphism in the dopamine D2 receptor gene may confer susceptibility to schizophrenia in Asian populations , 2016, Journal of Clinical Neuroscience.

[12]  A. McQuillin,et al.  CACNA1C hypermethylation is associated with bipolar disorder , 2016, Translational psychiatry.

[13]  Wenhua Zhu,et al.  Genetic analysis of SNPs in CACNA1C and ANK3 gene with schizophrenia: A comprehensive meta‐analysis , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  M. Owen,et al.  Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders , 2015, Progress in Neurobiology.

[15]  M. Walterfang,et al.  Secondary psychosis induced by metabolic disorders , 2015, Front. Neurosci..

[16]  L. Tsai,et al.  Erratum: Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons , 2015, Molecular Psychiatry.

[17]  R. Lu,et al.  Exploring the associations between genetic variants in genes encoding for subunits of calcium channel and subtypes of bipolar disorder. , 2014, Journal of affective disorders.

[18]  G. Zunta-Soares,et al.  Candidate gene associations with mood disorder, cognitive vulnerability, and fronto-limbic volumes , 2014, Brain and behavior.

[19]  Tzu-Yun Wang,et al.  Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. , 2013, Journal of affective disorders.

[20]  Federico Turkheimer,et al.  Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. , 2013, Brain : a journal of neurology.

[21]  Chunyu Liu,et al.  A rare mutation of CACNA1C in a patient with Bipolar disorder, and decreased gene expression associated with a Bipolar-associated common SNP of CACNA1C in brain , 2013, Molecular Psychiatry.

[22]  Ting Shen,et al.  Functional −141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population , 2013, The Journal of international medical research.

[23]  D. Camerino,et al.  Major channels involved in neuropsychiatric disorders and therapeutic perspectives , 2013, Front. Genet..

[24]  F. Holsboer,et al.  ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples. , 2012, Journal of psychiatric research.

[25]  Mark Slifstein,et al.  The nature of dopamine dysfunction in schizophrenia and what this means for treatment. , 2012, Archives of general psychiatry.

[26]  Pamela B. Mahon,et al.  Meta‐analysis of genetic association studies on bipolar disorder , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[27]  J. Lieberman,et al.  Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: Replication and exploration , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[28]  Y. Zou,et al.  Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis. , 2012, Journal of affective disorders.

[29]  Isabella Pisano,et al.  Identification of a novel Sp1 splice variant as a strong transcriptional activator. , 2011, Biochemical and biophysical research communications.

[30]  Y. S. Zhu,et al.  Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction , 2010, Brain Research.

[31]  Y. Forsell,et al.  Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. , 2010, Journal of affective disorders.

[32]  M C O'Donovan,et al.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia , 2009, Molecular Psychiatry.

[33]  Celso Arango,et al.  DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first‐episode psychosis adolescents , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[34]  Manuel A. R. Ferreira,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[35]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[36]  R. Qamar,et al.  VNTR polymorphism of the DRD4 locus in different Pakistani ethnic groups. , 2008, Genetic testing.

[37]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[38]  C. Nemeroff,et al.  The role of dopamine in the pathophysiology of depression. , 2007, Archives of general psychiatry.

[39]  Nicholas C. Spitzer,et al.  Electrical activity in early neuronal development , 2006, Nature.

[40]  G. Williams,et al.  Under the curve: Critical issues for elucidating D1 receptor function in working memory , 2006, Neuroscience.

[41]  B. Lerer,et al.  Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms , 2006, Pharmacogenetics and genomics.

[42]  C. Chillotti,et al.  A48G polymorphism in the D1 receptor genes associated with bipolar I disorder , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[43]  J. Hauser,et al.  An association study of dopamine receptors polymorphisms and the Wisconsin Card Sorting Test in schizophrenia , 2005, Journal of Neural Transmission.

[44]  K. D. Jakobsen,et al.  Association of the 120-bp duplication in the dopamine D4 receptor gene and schizophrenia in a sample of Danish subjects , 2005, Schizophrenia Research.

[45]  I. Craig,et al.  Functional effects of a tandem duplication polymorphism in the 5′flanking region of the DRD4 gene , 2004, Biological Psychiatry.

[46]  Xun Hu,et al.  Association analysis of the DRD4 and COMT genes in methamphetamine abuse , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[47]  P. Joyce,et al.  Association of a duplicated repeat polymorphism in the 5′‐untranslated region of the DRD4 gene with novelty seeking , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[48]  G. Keszler,et al.  Capillary electrophoresis study on DNA-protein complex formation in the polymorphic 5' upstream region of the dopamine D4 receptor (DRD4) gene. , 2004, Current medicinal chemistry.

[49]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[50]  Ricardo Segurado,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: Methods and power analysis. , 2003, American journal of human genetics.

[51]  D. Goldenberg.  Psychiatric and neuropsychiatric manifestations of HIV infection. , 2003, Journal of the International Association of Physicians in AIDS Care.

[52]  W James Gauderman,et al.  Sample size requirements for matched case‐control studies of gene–environment interaction , 2002, Statistics in medicine.

[53]  S. Nelson,et al.  Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD) , 2000, Molecular Psychiatry.

[54]  J. Soares,et al.  The diagnostic boundaries of bipolar disorder. , 2000, Bipolar disorders.

[55]  T. Arinami,et al.  A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. , 1997, Human molecular genetics.

[56]  M. Caron,et al.  Dopamine receptor subtypes: beyond the D1/D2 classification. , 1990, Trends in pharmacological sciences.

[57]  J. R. Wittenborn.  DEDUCTIVE APPROACHES TO THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS , 1974, The Journal of nervous and mental disease.

[58]  Tao Li,et al.  CACNA1C, schizophrenia and major depressive disorder in the Han Chinese population. , 2014, The British journal of psychiatry : the journal of mental science.

[59]  M Masellis,et al.  D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine , 2003, Molecular Psychiatry.

[60]  P. Riederer,et al.  Insertion/deletion variant (−141C Ins/Del) in the 5′ regulatory region of the dopamine D2 receptor gene: lack of association with schizophrenia and bipolar affective disorder , 1998, Journal of Neural Transmission.

[61]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[62]  D. Grandy,et al.  Molecular diversity of the dopamine receptors. , 1993, Annual review of pharmacology and toxicology.

[63]  R. Tissot.  The common pathophysiology of monaminergic psychoses: a new hypothesis. , 1975, Neuropsychobiology.